Psychedelic-Assisted Psychotherapy

doi:10.1017/9781108686976.030

Chapter 28 - Psychedelic-Assisted Psychotherapy

from Section 3 - Contemporary Developments

Published online by Cambridge University Press: 27 May 2021

Tim Read

Edited by

Rachel Gibbons and

Jo O'Reilly

Book contents

Get access

Summary

In recent years there has been a resumption of research into the potential therapeutic benefits of psychedelic1 drugs such as MDMA2, psilocybin and LSD3. Clinical research suggests significant efficacy for psychiatric disorders that have traditionally been hard to treat. The evidence base has accumulated to the point that psychedelic-assisted psychotherapy appears to be moving from a fringe subject to a significant new treatment method that all psychotherapists should at least be aware of and that some may develop into a special interest.

Type: Chapter
Information: Seminars in the Psychotherapies , pp. 363 - 372

DOI: https://doi.org/10.1017/9781108686976.030 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Freud, S. An outline of psycho-analysis. In Strachey, J, ed., The Standard Edition of the Complete Psychological Works of Sigmund Freud, Volume XXIII (1937–1939). Moses and Monotheism, An Outline of Psycho-Analysis and Other Works. London: Hogarth Press. 1964; pp. 139–208. (Original work published 1938)Google Scholar

Mithoefer, MC, Mithoefer, AT, Feduccia, AA et al. 3,4-methylenedioxymethamphetamine (MDMA) psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Lancet Psychiatry 2018; 5(6): 486–97.CrossRef Google Scholar PubMed

Mithoefer, M, Mithoefer, A, Jerome, L et al. A manual for MDMA-assisted psychotherapy in the treatment of PTSD (version 8). http://www.maps.org/research/mdma/mdma-research-timeline/4887-a-manual-for-mdma-assisted-psychotherapy-in-the-treatment-of-ptsd [Accessed 23/11/2020]Google Scholar

Sessa, B. The Psychedelic Renaissance, 2nd ed. London: Muswell Hill Press. 2017; p. 41.Google Scholar PubMed

Carhart-Harris, RL, Murphy, K, Leech, R et al. The effects of acutely administered 3,4-methylenedioxymethamphetamine on spontaneous brain function in healthy volunteers measured with arterial spin labeling and blood oxygen level-dependent resting state functional connectivity. Biol Psychiatry 2015; 78(8): 554–62.Google Scholar

Mithoefer, M. MDMA-assisted psychotherapy: how different is it from other psychotherapy? MAPS Bulletin Special Edition, Spring 2013. www.maps.org/news-letters/v23n1/v23n1_p10-14.pdf> [Accessed 23/11/2020]+[Accessed+23/11/2020]>Google Scholar

Gasser, P, Holstein, D, Michel, Y et al. Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. J Nerv Ment Dis 2014; 202(7): 513–20.Google Scholar

Hoffman, A. LSD My Problem Child, 2nd ed. Sarasota FL: MAPS, 2005.Google Scholar

Roseman, L, Nutt, D, Carhart-Harris, RL. Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Front Pharmacol 2018; 8: 974.Google Scholar

Carhart-Harris, RL, Bolstridge, M, Rucker, J et al. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry 2016; 3(7): 619–27.Google Scholar

Kurland, A, Savage, C, Pahnke, WN, Grof, S, Olsson, JE. LSD in the treatment of alcoholics. Pharmacopsychiatry 1971; 4(2): 83–94.Google Scholar

Kast, E. LSD and the dying patient. Chic Med Sch Q 1966; 26(2): 80–7.Google Scholar

Pahnke, WN, Kurland, AA, Goodman, LE, Richards, WA. LSD-assisted psychotherapy with terminal cancer patients. Curr Psychiatr Ther 1969; 9: 144–52.Google Scholar PubMed

Cohen, S. Lysergic acid diethylamide: side effects and complications. J Nerv Ment Dis 1960; 130: 30–40.Google Scholar

Griffiths, RR, Bigelow, GE, Henningfield, JE. Similarities and animal and human drug-taking behaviour. In Mello, NK, ed., Advances in Substance Abuse. Vol. 1. Greenwich: JAI Press. 1980; pp. 1–90.Google Scholar

Griffiths, RR, Richards, WA, McCann, U, Jesse, R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 2006; 187: 268–83.Google Scholar

Grof, S. Realms of the Human Unconscious: Observations from LSD Research. New York: Viking, 1975.Google Scholar

Cutner, M. Analytic work with LSD. Psychiatr Q 1969; 33: 715–57.Google Scholar

Piontelli, A. From Fetus to Child: Observational and Psychoanalytical Study. Hove: Routledge, 1992.Google Scholar